Centers for Disease Control and Prevention, Atlanta, GA 30341, USA.
Contraception. 2010 Jul;82(1):3-9. doi: 10.1016/j.contraception.2010.02.014. Epub 2010 Mar 29.
The Centers for Disease Control and Prevention (CDC) recently adapted global guidance on contraceptive use from the World Health Organization (WHO) to create the United States Medical Eligibility Criteria for Contraceptive Use (MEC). This guidance includes recommendations for use of specific contraceptive methods by people with certain characteristics or medical conditions.
CDC determined the need and scope for the adaptation, conducted 12 systematic reviews of the scientific evidence and convened a meeting of health professionals to discuss recommendations based on the evidence.
The vast majority of the US guidance is the same as the WHO guidance and addresses over 160 characteristics or medical conditions. Modifications were made to WHO recommendations for six medical conditions, and recommendations were developed for six new medical conditions.
The US MEC is intended to serve as a source of clinical guidance for providers as they counsel clients about contraceptive method choices.
疾病控制与预防中心（CDC）最近根据世界卫生组织（WHO）的全球避孕使用指南进行了调整，制定了美国避孕使用医学标准（MEC）。该指南包括针对某些特征或医疗状况的特定避孕方法的使用建议。
CDC 确定了适应的必要性和范围，对 12 项科学证据进行了系统评价，并召开了一次卫生专业人员会议，根据证据讨论建议。
美国的指导意见绝大部分与世界卫生组织的指导意见相同，涉及 160 多种特征或医疗状况。对 6 种医疗状况的世界卫生组织建议进行了修改，并为 6 种新的医疗状况制定了建议。
美国 MEC 旨在为提供者提供临床指导，帮助他们为客户提供避孕方法选择方面的建议。
